The Journal of Clinical Endocrinology & Metabolism · 2013 · 95 citations · 14 references
MedicineOncologySurgeryMetastasisOncologic SurgerySurgical OncologyCervical Lymph Node MetastasisMetastatic Cervical Lymph Node DiseaseThyroid CancerThyroid ImagingThyroid SurgeryThyroid UltrasonographyContrast-enhanced Thyroid UltrasoundLaser AblationLocal Control AssessmentLocal Disease ControlPapillary Thyroid Carcinoma SurgeryPercutaneous AblationThyroid Cancer LymphadenectomyThyroid Carcinoma Metastasis To Lymph Nodes
CONTEXT: Percutaneous laser ablation (PLA) may be useful in treating patients with metachronous metastatic lymph nodes in the neck. OBJECTIVE: Our objective was to assess PLA as a treatment of difficult-to-treat metachronous cervical lymph node metastases from papillary thyroid carcinoma. DESIGN AND SETTING: We conducted a retrospective analysis of prospectively collected data at a public hospital. PATIENTS: Fifteen patients with previous resection of papillary thyroid carcinoma with elevated serum levels of thyroglobulin (Tg) or anti-Tg antibodies (TgAbs) and 24 metachronous nodal metastases treated between September 2010 and April 2012 were followed with [¹⁸F]fluorodeoxyglucose (¹⁸FDG) positron emission tomography (PET)/computed tomography (CT) and contrast-enhanced ultrasound (CEUS). INTERVENTION: Intervention was PLA. OUTCOME MEASURES: Technique feasibility and technical success were evaluated. Tg/TgAb serum levels and ¹⁸FDG-PET/CT, and CEUS appearance were assessed at 6 and 12 months and compared with baseline. Complications were recorded. RESULTS: PLA was always feasible, and technical success was achieved in all patients. At 6 months, local control was achieved in 11 of 15 patients (73%), with 6 (40%) having serum Tg/TgAb normalized (P = .017 vs baseline). Whereas 20 of 24 (83%) nodes were negative at ¹⁸FDG-PET/CT and CEUS (P < .001 vs baseline), 4 were ¹⁸FDG-PET/CT-positive (3 also CEUS-positive). At the 12-month follow-up, local control was achieved in 10 of 14 patients (71.4%). Sixteen of 20 nodes (80%) were negative at ¹⁸FDG-PET/CT and CEUS (P < .001 vs baseline), 4 were ¹⁸FDG-PET/CT-positive (2 also CEUS-positive). Four of 10 (40%) patients had normalization of serum Tg/TgAb (P = .098 vs baseline). No major complications occurred. CONCLUSIONS: PLA is potentially feasible, safe, and effective for the treatment of metachronous cervical nodal metastases from papillary thyroid carcinoma. This procedure may reduce or delay a large number of highly invasive repeat neck dissections.
14
Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006
Briseis Aschebrook‐Kilfoy, Mary H. Ward, Mona M. Sabra et al. · Thyroid · 2010 · 458 citations
Medicine, Endocrinology, Oncology +17
Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy
Damian E. Dupuy, John M. Monchik, Carmen Decrea et al. · Surgery · 2001 · 239 citations
Medicine, Oncology, Otolaryngology +15